Financial Ratios

MOREPEN LABORATORIES LTD.

NSE : MOREPENLABBSE : 500288ISIN CODE : INE083A01026Industry : Pharmaceuticals & DrugsHouse : Morepen
BSE48.632.06 (+4.42 %)
PREV CLOSE ( ) 46.57
OPEN PRICE ( ) 46.27
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 641008
TODAY'S LOW / HIGH ( )45.51 49.80
52 WK LOW / HIGH ( )25.34 56.35
NSE49.052.45 (+5.26 %)
PREV CLOSE( ) 46.60
OPEN PRICE ( ) 46.00
BID PRICE (QTY) 49.05 (43651)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8190384
TODAY'S LOW / HIGH( ) 45.40 49.75
52 WK LOW / HIGH ( )25.1 56.4
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.902.122.100.720.64
   CEPS(Rs)1.262.562.721.481.48
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)15.2611.978.926.836.17
   Tax Rate(%)26.6519.500.0013.740.00
Margin Ratios
   Core EBITDA Margin(%)5.778.9110.108.149.07
   EBIT Margin(%)4.868.838.634.984.28
   Pre Tax Margin(%)4.718.668.474.733.99
   PAT Margin (%)3.456.978.474.083.99
   Cash Profit Margin (%)4.808.4411.008.439.29
Performance Ratios
   ROA(%)4.3210.7512.495.054.73
   ROE(%)6.8420.7726.6111.0610.84
   ROCE(%)9.1523.7324.5410.827.74
   Asset Turnover(x)1.251.541.471.241.19
   Sales/Fixed Asset(x)2.702.911.921.120.86
   Working Capital/Sales(x)3.045.299.5041.95-19.13
Efficiency Ratios
   Fixed Capital/Sales(x)0.370.340.520.901.16
   Receivable days65.0747.5245.4356.0859.08
   Inventory Days64.0153.8849.5651.4641.93
   Payable days92.6981.1292.58118.01130.87
Valuation Parameters
   PER(x)28.3917.3015.3413.2727.11
   PCE(x)20.4314.3011.826.4311.65
   Price/Book(x)1.683.063.601.402.80
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.961.191.260.511.22
   EV/Core EBITDA(x)15.4411.5411.255.4712.74
   EV/EBIT(x)19.7113.4514.5410.2528.52
   EV/CE(x)1.161.671.650.611.41
   M Cap / Sales0.981.211.300.541.08
Growth Ratio
   Net Sales Growth(%)-7.6230.2840.4610.4227.89
   Core EBITDA Growth(%)-44.3420.1568.037.567.65
   EBIT Growth(%)-49.1933.25143.4428.560.90
   PAT Growth(%)-54.247.23191.4913.009.57
   EPS Growth(%)-57.230.94191.5112.999.58
Financial Stability Ratios
   Total Debt/Equity(x)0.030.030.040.040.47
   Current Ratio(x)2.511.681.311.060.88
   Quick Ratio(x)1.791.040.860.660.60
   Interest Cover(x)32.8352.7553.7120.0514.82
   Total Debt/Mcap(x)0.020.010.010.030.17

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.